A study for a 49 year old woman who takes Gleevec - from FDA reports


2,058 females aged 49 (±5) who take the same drug are studied. This is a personalized study for a 49 year old female patient who has Chronic Myelogenous Leukemia (Cml). The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Sep, 15, 2018

2,058 females aged 49 (±5) who take Gleevec are studied.


Number of reports submitted per year:

Gleevec for a 49-year old woman.

Information of the patient in this study:

  • Age: 49
  • Gender: female
  • Conditions: Chronic Myelogenous Leukemia (Cml)
  • Drugs taken:
    • Gleevec (imatinib mesylate)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Rashes (redness)
  2. Nausea (feeling of having an urge to vomit)
  3. White blood cell count decreased
  4. Headache (pain in head)
  5. Breathing difficulty
1 - 6 months:
  1. Fatigue (feeling of tiredness)
  2. Malignant neoplasm progression (cancer tumour came back)
  3. Nausea (feeling of having an urge to vomit)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Nausea and vomiting
6 - 12 months:
  1. Rashes (redness)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Fever
  4. Oedema peripheral (superficial swelling)
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
1 - 2 years:
  1. Fatigue (feeling of tiredness)
  2. Nausea and vomiting
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Haemoglobin decreased
  5. Joint pain
2 - 5 years:
  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhea
  3. Gastrointestinal stromal tumor
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Death
5 - 10 years:
  1. Fever
  2. Nausea (feeling of having an urge to vomit)
  3. Chest pain
  4. High blood pressure
  5. White blood cell count increased
10+ years:
  1. Diarrhea
  2. Bone density decreased
  3. Oral pain
  4. Rashes (redness)
  5. Mesenteric artery thrombosis (blood clot in mesenteric artery)
not specified:
  1. Death
  2. Nausea (feeling of having an urge to vomit)
  3. Diarrhea
  4. Rashes (redness)
  5. Fatigue (feeling of tiredness)

Top conditions involved for these people *:

  1. Gastrointestinal Stromal Tumor : 233 people, 11.32%
  2. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 95 people, 4.62%
  3. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 50 people, 2.43%
  4. Neoplasm Malignant (cancer tumour): 29 people, 1.41%
  5. Depression : 29 people, 1.41%

Top co-used drugs for these people *:

  1. Tasigna (53 people, 2.58%)
  2. Methotrexate (36 people, 1.75%)
  3. Lasix (33 people, 1.60%)
  4. Allopurinol (32 people, 1.55%)
  5. Zofran (30 people, 1.46%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?



Related studies:

Related publications that referenced our studies

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.